| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0002-9149(02)02464-5 |
| P698 | PubMed publication ID | 12127613 |
| P50 | author | Emelia J. Benjamin | Q28754501 |
| Ramachandran S. Vasan | Q30348351 | ||
| Martin G Larson | Q37390385 | ||
| Torbjørn Omland | Q65675689 | ||
| Thomas J. Wang | Q80460150 | ||
| Daniel Levy | Q88264418 | ||
| Peter Wilson | Q89854449 | ||
| Patrice A Sutherland | Q114427800 | ||
| P2093 | author name string | Eric P Leip | |
| P2860 | cites work | Possibility of age regulation of the natriuretic peptide C-receptor in human platelets. | Q32066588 |
| Estrogen, natriuretic peptides and the renin-angiotensin system | Q33704109 | ||
| Influence of Age and Dose on the End-Organ Responses to Atrial Natriuretic Peptide in Humans | Q41130251 | ||
| Atrial and brain natriuretic peptides in cardiovascular diseases | Q42504247 | ||
| Determinants of interindividual variation of renin and prorenin concentrations: evidence for a sexual dimorphism of (pro)renin levels in humans | Q44917492 | ||
| Biochemical detection of left-ventricular systolic dysfunction | Q48562979 | ||
| Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy | Q48853320 | ||
| Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction | Q48963969 | ||
| Cardiac chamber-specific alterations of ANP and BNP expression with advancing age and with systemic hypertension | Q48985470 | ||
| Plasma atrial natriuretic peptide and natriuretic peptide receptor gene expression in adipose tissue of normotensive and hypertensive obese patients. | Q51571442 | ||
| Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension. | Q51580898 | ||
| The influence of gender, age, and the menstrual cycle on plasma atrial natriuretic peptide. | Q51617048 | ||
| RAISED CIRCULATING LEVELS OF ATRIAL NATRIURETIC PEPTIDES IN ESSENTIAL HYPERTENSION | Q57943455 | ||
| An investigation of coronary heart disease in families. The Framingham offspring study | Q59461737 | ||
| Circulating N-terminal pro-atrial natriuretic peptide is an independent predictor of left ventricular hypertrophy in the general population The Tromsø Study | Q60690186 | ||
| Correlates of plasma atrial natriuretic factor in health and hypertension | Q61460462 | ||
| Estradiol, progesterone and testosterone exposures affect the atrial natriuretic peptide gene expression in vivo in rats | Q68056460 | ||
| High plasma concentrations of human atrial natriuretic polypeptide in aged men | Q70154267 | ||
| Circulating N-terminal atrial natriuretic peptide as a marker for symptomless left-ventricular dysfunction | Q72217384 | ||
| Why is the concentration of plasma brain natriuretic peptide in elderly inpatients greater than normal? | Q73185744 | ||
| Measurement of brain natriuretic peptide in plasma samples and cardiac tissue extracts by means of an immunoradiometric assay method | Q73806481 | ||
| Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care | Q73868164 | ||
| Natriuretic peptides | Q74817622 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 254-258 | |
| P577 | publication date | 2002-08-01 | |
| P1433 | published in | American Journal of Cardiology | Q2208417 |
| P1476 | title | Impact of age and sex on plasma natriuretic peptide levels in healthy adults | |
| P478 | volume | 90 |
| Q22306358 | 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines |
| Q64972630 | 2019 Focused Update of the Guidelines of the Taiwan Society of Cardiology for the Diagnosis and Treatment of Heart Failure. |
| Q35201772 | A personalized medicine target: heart failure in women |
| Q61456285 | Accuracy of B-natriuretic peptide for the diagnosis of decompensated heart failure in muscular dystrophies patients with chronic respiratory failure |
| Q43265429 | Adjusting for clinical covariates improves the ability of B-type natriuretic peptide to distinguish cardiac from non-cardiac dyspnoea: a sub-study of HEARD-IT. |
| Q37108057 | Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction |
| Q48725250 | Analytical evaluation of the Dade Behring Dimension RxL automated N-Terminal proBNP (NT-proBNP) method and comparison with the Roche Elecsys 2010. |
| Q47829708 | Analytical performance and diagnostic accuracy of a fully-automated electrochemiluminescent assay for the N-terminal fragment of the pro-peptide of brain natriuretic peptide in patients with cardiomyopathy: comparison with immunoradiometric assay me |
| Q48460667 | Aortic stiffness is an independent determinant of B-type natriuretic peptide in patients with coronary artery disease |
| Q36886130 | Arterial Remodeling in B-Type Natriuretic Peptide Knock-Out Females |
| Q37148149 | Association of common variants in NPPA and NPPB with circulating natriuretic peptides and blood pressure |
| Q40275959 | Associations of Proatrial Natriuretic Peptide with Components of the Metabolic Syndrome in Adolescents and Young Adults from the General Population |
| Q52140564 | Associations of serum n-3 and n-6 polyunsaturated fatty acids with plasma natriuretic peptides. |
| Q35968889 | B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide in pediatric patients with pulmonary arterial hypertension. |
| Q47401486 | B-type natriuretic peptide for diagnosis of heart failure in emergency department patients: a critical appraisal |
| Q48237778 | B-type natriuretic peptide in cardiovascular disease |
| Q37833104 | B-type natriuretic peptide measurement in primary care; magnitude of associations with cardiovascular risk factors and their therapies. Observations from the STOP-HF (St. Vincent's Screening TO Prevent Heart Failure) study. |
| Q34954819 | B-type natriuretic peptides improve cardiovascular disease risk prediction in a cohort of women |
| Q79180914 | B-type ventricular peptide |
| Q92127154 | BNP as a Major Player in the Heart-Kidney Connection |
| Q35570395 | BNP as discharge criteria for heart failure |
| Q34369603 | BNP molecular forms and processing by the cardiac serine protease corin |
| Q33927398 | Biomarkers and cardiovascular risk assessment for primary prevention: an update |
| Q36763168 | Biomarkers and mortality after transient ischemic attack and minor ischemic stroke: population-based study |
| Q38212008 | Biomarkers in cardiorenal syndromes |
| Q37597779 | Biomarkers in outpatient heart failure management; Are they correlated to and do they influence clinical judgment? |
| Q36148152 | Brain natriuretic hormone predicts stress-induced alterations in diastolic function |
| Q48234513 | Brain natriuretic peptide detects cardiac abnormalities in mass screening. |
| Q33573360 | Brain natriuretic peptide in pulmonary arterial hypertension: biomarker and potential therapeutic agent |
| Q36050481 | Brain natriuretic peptide in the contemporary management of congestive heart failure |
| Q33692402 | Brain natriuretic peptide precursor (NT-pro-BNP) levels predict for clinical benefit to sunitinib treatment in patients with metastatic renal cell carcinoma |
| Q37427570 | Cardiometabolic Risk in Hyperlipidemic Men and Women. |
| Q26745756 | Cardiopulmonary laboratory biomarkers in the evaluation of acute dyspnea |
| Q36382621 | Cardiovascular and metabolic effects of natriuretic peptides |
| Q38543356 | Cardiovascular biomarkers and sex: the case for women |
| Q37424605 | Cardiovascular disease risk prediction in women: is there a role for novel biomarkers? |
| Q28396627 | Cardiovascular sex differences influencing microvascular exchange |
| Q36753860 | Changes in brain natriuretic peptide are correlated with changes in global end-diastolic volume index |
| Q35611405 | Circulating C-type natriuretic peptide and its relationship to cardiovascular disease in the general population |
| Q95260893 | Circulating biomarkers in the early detection of hypertensive heart disease: usefulness in the developing world |
| Q92661558 | Clinical Applications of Natriuretic Peptides in Heart Failure and Atrial Fibrillation |
| Q35207721 | Clinical and echocardiographic correlates of plasma procollagen type III amino-terminal peptide levels in the community |
| Q33706806 | Clinical criteria replenish high-sensitive troponin and inflammatory markers in the stratification of patients with suspected acute coronary syndrome |
| Q36442407 | Clinical relevance of biological variation: the lesson of brain natriuretic peptide (BNP) and NT-proBNP assay. |
| Q51736814 | Clinical significance of N-terminal-probrain natriuretic peptide in hypertrophic cardiomyopathy. |
| Q53289546 | Corin Is Present in the Normal Human Heart, Kidney, and Blood, with Pro–B-Type Natriuretic Peptide Processing in the Circulation |
| Q35573378 | Correlation between B-Type Natriuretic Peptide and Functional/Cognitive Parameters in Discharged Congestive Heart Failure Patients |
| Q51102049 | Cystatin C: a potential biomarker for pulmonary arterial hypertension. |
| Q47973132 | Diagnostic value of a rapid test for B-type natriuretic peptide in patients presenting with acute dyspnoe: effect of age and gender |
| Q92533310 | Effect of Testosterone on Natriuretic Peptide Levels |
| Q35114062 | Effects of oral contraceptives on natriuretic peptide levels in women with hypothalamic amenorrhea: a pilot study. |
| Q35718016 | Effects of transdermal testosterone on natriuretic peptide levels in women: a randomized placebo-controlled pilot study |
| Q58759286 | Establishment of normal reference values of NT-proBNP and its application in diagnosing acute heart failure in children with severe hand food and mouth disease |
| Q44756164 | Ethnic, geographic and dietary influences upon vasoactive hormones and blood pressure among Greenland Inuit and Danes |
| Q39179788 | Feasibility and interpretation of global longitudinal strain imaging in pediatric heart transplant recipients |
| Q47313710 | GDF-15 (Growth Differentiation Factor 15) Is Associated With Lack of Ventricular Recovery and Mortality After Transcatheter Aortic Valve Replacement. |
| Q53506123 | Galectin-3 levels are associated with right ventricular functional and morphologic changes in pulmonary arterial hypertension. |
| Q44050644 | Gender aspects in clinical presentation and prognostication of chronic heart failure according to NT-proBNP and the Heart Failure Survival Score |
| Q37044313 | Gender aspects of the role of the metabolic syndrome as a risk factor for cardiovascular disease |
| Q37919535 | Gender-specific differences in biomarkers responses to acute coronary syndromes and revascularization procedures |
| Q39095620 | Gender-specific research for emergency diagnosis and management of ischemic heart disease: proceedings from the 2014 Academic Emergency Medicine Consensus Conference Cardiovascular Research Workgroup. |
| Q92925812 | Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations |
| Q37637447 | Heart Failure in Women--Insights from the Framingham Heart Study |
| Q55072161 | Heart Failure in Women. |
| Q37001576 | Heart failure in elderly: progress in clinical evaluation and therapeutic approach |
| Q35058920 | Higher serum concentrations of N-terminal pro-B-type natriuretic peptide associate with prevalent hypertension whereas lower associate with incident hypertension |
| Q35685066 | Identifying biomarker patterns and predictors of inflammation and myocardial stress. |
| Q47963870 | Impact of Protein Nutritional Status on Plasma BNP in Elderly Patients |
| Q92627593 | Importance of Basal Metabolic Index in the Diagnosis of Heart Failure With B-Type Natriuretic Peptide |
| Q41548532 | Increase in N-terminal pro-brain natriuretic peptide levels, renal function and cardiac disease in the oldest old. |
| Q92353809 | Independent Impact of Gynoid Fat Distribution and Free Testosterone on Circulating Levels of N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) in Humans |
| Q48272609 | Inflammation increases NT-proBNP and the NT-proBNP/BNP ratio |
| Q49158567 | Influence of age on natriuretic peptides in patients with chronic heart failure: a comparison between ANP/NT-ANP and BNP/NT-proBNP. |
| Q46107789 | Influence of age, race, sex, and body mass index on interpretation of midregional pro atrial natriuretic peptide for the diagnosis of acute heart failure: results from the BACH multinational study |
| Q48278408 | Influence of gender on circulating cardiac natriuretic hormones in patients with heart failure |
| Q35207706 | Influence of sex and hormone status on circulating natriuretic peptides |
| Q47836822 | Left ventricular regional myocardial motion and twist function in repaired tetralogy of Fallot evaluated by magnetic resonance tissue phase mapping. |
| Q48403295 | Long-term heart function after adjuvant epirubicin chemotherapy for breast cancer |
| Q34357369 | Multimarker approach for the prediction of heart failure incidence in the community |
| Q43264877 | N-terminal ProBNP distribution and correlations with biological characteristics in apparently healthy Greek population: ATTICA study |
| Q51451869 | N-terminal pro-B-type natriuretic peptide in early and advanced phases of obesity. |
| Q37583858 | N-terminal pro-B-type natriuretic peptide level inversely associates with metabolic syndrome in elderly persons. |
| Q83240814 | N-terminal pro-atrial natriuretic peptide reflects cardiac remodelling in stage 1 hypertension |
| Q37368214 | N-terminal pro-brain natriuretic peptide in systemic lupus erythematosus: relationship with inflammation, augmentation index, and coronary calcification |
| Q36181411 | NH2-terminal probrain natriuretic peptide is associated with diabetes complications in the EURODIAB Prospective Complications Study: the role of tumor necrosis factor-α. |
| Q35244261 | NT pro B type natriuretic peptide levels in constrictive pericarditis and restrictive cardiomyopathy |
| Q37182523 | NT-proBNP in Children With Left to Right Shunt and Dilated Cardiomyopathy |
| Q33572286 | Natriuretic Peptide testing in primary care |
| Q35577463 | Natriuretic peptide measurement as a screening test for overt and subclinical heart failure |
| Q90717399 | Natriuretic peptide-guided treatment for the prevention of cardiovascular events in patients without heart failure |
| Q47594480 | Natriuretic peptides as markers of preclinical cardiac disease in obesity. |
| Q37638155 | Natriuretic peptides in heart failure: should therapy be guided by BNP levels? |
| Q38120091 | Natriuretic peptides: molecular biology, pathophysiology and clinical implications for the cardiologist. |
| Q94355182 | Natriuretic peptide‐guided treatment for the prevention of cardiovascular events in patients without heart failure |
| Q51000455 | Neurohormonal and clinical sex differences in heart failure. |
| Q35581437 | Normal values of B type natriuretic peptide in infants, children, and adolescents |
| Q48239494 | Novel Vasoregulatory Aspects of Hereditary Angioedema: the Role of Arginine Vasopressin, Adrenomedullin and Endothelin-1. |
| Q30484493 | Novel strategies for the detection of systolic and diastolic heart failure |
| Q49042649 | Nt-proANP in plasma, a marker of salt sensitivity, is reduced in type 2 diabetes patients |
| Q38883831 | Ovarian hormones and obesity. |
| Q81041052 | Paradoxical relationship between B-type natriuretic peptide and pulmonary vascular resistance in patients with ventricular septal defect and concomitant severe pulmonary hypertension |
| Q39145463 | Plasma B-type natriuretic peptide is a useful tool for assessing coronary heart disease risk in a Japanese general population |
| Q48187642 | Plasma N terminal pro-brain natriuretic peptide levels and its determinants in a multi-ethnic population |
| Q34161212 | Plasma levels of alpha-1-antichymotrypsin are elevated in patients with chronic heart failure, but are of limited prognostic value. |
| Q37364330 | Plasma midregional pro-atrial natriuretic peptide is associated with blood pressure indices and hypertension severity in adults with hypertension |
| Q83242531 | Predictive value of B-type natriuretic peptide levels in patients with paroxysmal and persistent atrial fibrillation undergoing pulmonary vein isolation |
| Q37591134 | Pro-B-type natriuretic peptide(1-108) circulates in the general community: plasma determinants and detection of left ventricular dysfunction |
| Q37182338 | Prognostic value of N-terminal pro-brain natriuretic peptide in elderly people with acute myocardial infarction: prospective observational study |
| Q44825812 | Psychosocial correlates of atrial natriuretic peptide: a marker of vascular health |
| Q47425600 | Racial Differences in Plasma Levels of N-Terminal Pro-B-Type Natriuretic Peptide and Outcomes: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study |
| Q48711307 | Reduced brain natriuretic peptide levels in class III obesity: the role of metabolic and cardiovascular factors. |
| Q35532063 | Reference limits for N-terminal-pro-B-type natriuretic peptide in healthy individuals (from the Framingham Heart Study). |
| Q48149929 | Reference ranges for natriuretic peptides for diagnostic use are dependent on age, gender and heart rate |
| Q37172401 | Relation of N-terminal pro-B-type natriuretic peptide with diastolic function in hypertensive heart disease. |
| Q35218885 | Relation of visceral adiposity to circulating natriuretic peptides in ambulatory individuals |
| Q35674117 | Relationship between N-terminal pro-B-type natriuretic peptide levels and metabolic syndrome |
| Q64890058 | Relationship of brain natriuretic peptide concentrations to left ventricular function and adverse outcomes in children with end-stage renal disease undergoing hemodialysis. |
| Q38089931 | Review on natriuretic peptides: where we are, where we are going |
| Q36473364 | Screening for ventricular remodeling |
| Q37092258 | Serial monitoring of brain natriuretic peptide concentrations for drug therapy management in patients with chronic heart failure |
| Q51280778 | Serum proatrial natriuretic peptide does not increase with higher systolic blood pressure in obese men. |
| Q47644063 | Sex Differences and Similarities in Atrial Fibrillation Epidemiology, Risk Factors, and Mortality in Community Cohorts: Results From the BiomarCaRE Consortium (Biomarker for Cardiovascular Risk Assessment in Europe). |
| Q90181215 | Sex Differences in Circulating Biomarkers of Cardiovascular Disease |
| Q44926885 | Sex-specific differences in natriuretic peptide and nitric oxide synthase expression in ANP gene-disrupted mice |
| Q35508766 | Statin therapy decreases N-terminal pro-B-type natriuretic peptide in HIV: randomized placebo-controlled trial |
| Q58752679 | Systems Genetics Approach to Biomarker Discovery: GPNMB and Heart Failure in Mice and Humans |
| Q34616035 | The effect of the brain-type natriuretic peptide single-nucleotide polymorphism rs198389 on test characteristics of common assays |
| Q45011958 | The extent of myocardial damage assessed by contrast-enhanced MRI is a major determinant of N-BNP concentration after myocardial infarction |
| Q35206514 | The increasing impact of laboratory medicine on clinical cardiology |
| Q36273355 | The landscape of sex-differential transcriptome and its consequent selection in human adults |
| Q37869374 | The paradox of low BNP levels in obesity |
| Q34433995 | The plasma B-type natriuretic peptide levels are low in males with stable ischemic heart disease (IHD) compared to those observed in patients with non-IHD: a retrospective study |
| Q34561996 | The proposed role of plasma NT pro-brain natriuretic peptide in assessing cardiac remodelling in hypertensive African subjects |
| Q35566135 | The role of brain natriuretic peptide in population screening |
| Q35077539 | The sexual dimorphism of obesity |
| Q47780845 | The use of B-type natriuretic peptide in the management of elderly patients with acute dyspnoea |
| Q46632631 | Total plasma proANP increases with atrial dilatation in horses |
| Q34365069 | Usefulness of B-type natriuretic peptide (BNP) as a screen for left ventricular abnormalities in diabetes mellitus |
| Q36230380 | Usefulness of natriuretic peptides in primary health care: an exploratory study in elderly patients. |
| Q38727409 | Using the galectin-3 test to predict mortality in heart failure patients: a systematic review and meta-analysis. |
| Q51898949 | Value of BNP to estimate cardiac risk in patients on cardioactive treatment in primary care. |
| Q45117337 | What factors are associated with high plasma B-type natriuretic peptide levels in a general Japanese population? |
| Q38404244 | Women Undergoing Coronary Angiography for Myocardial Infarction or Who Present With Multivessel Disease Have a Poorer Prognosis Than Men. |
Search more.